Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Descartes-15 for Multiple Myeloma
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial is testing a new treatment for patients with advanced multiple myeloma. The treatment involves modifying the patient's own immune cells to target a protein called BCMA. The study will assess the safety
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.